Clinical trial
Prospective Cohort Study on Predicting the Progression of Diabetic Microangiopathy Using Multimodal Eye Imaging
NCT06727955 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Cohort Study on Predicting the Progression of Diabetic Microangiopathy Using Multimodal Eye Imaging
- Lead sponsor
- Peking University Third Hospital
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- January 1, 2025
- Completion date
- December 31, 2028
- Enrollment
- 250 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.